Skip to content

Ultrasound-guided Femoral Nerve Block Without Electrical Stimulation of Peripheral Nerves

Femoral Nerve Block: Comparison of the Effectiveness of Ultrasound Control Versus Ultrasound Control With Electrical Stimulation of Peripheral Nerves

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05209490
Acronym
USvsUSEPN
Enrollment
40
Registered
2022-01-26
Start date
2022-02-01
Completion date
2022-06-30
Last updated
2022-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Efficiency, Femoral Nerve, Nerve Block, Ultrasonography

Keywords

femoral nerve block, ultrasound guidance, electrical stimulation of peripheral nerves

Brief summary

There is little work comparing the effectiveness of a femoral nerve block performed only under US guidance or US plus electrical stimulation of the peripheral nerve (EPN). The authors have shown the same effectiveness of these techniques(1).But the effectiveness of the blockade of the femoral nerve (complete blockade) performed in different ways turned out to be low valve: 71.7% for ultrasound in combination with electrical stimulation versus 69% for only ultrasound guidance. Research hypothesis: the blockade of the femoral nerve performed only under ultrasound control has the same effectiveness as the blockade performed under the ultrasound control with EPN.

Interventions

PROCEDUREFemoral nerve blockade under ultrasound control with a peripheral nerve stimulator

Following the ultrasound visualization of the femoral nerve, a insulated injection needle was connected to the nerve stimulator . Under ultrasound visualization guidance, the needle of the electronic nerve stimulator was positioned at the sciatic nerve (in plane) from its lateral side at a slightly superior position . A marker for LA introduction was the visualization of the needle end near the nerve, and a positive muscular response . Subsequently, the introduction of LA solution was initiated.If LA was spreading from the lateral side down to the nerve, then the needle was replaced to the upper point of the nerve and the rest of LA was introduced, and vice versa . The presence of a complete and incomplete spread of LA along the entire circumference of the nerve was assessed. Correspondingly, if the anesthetic was spreading upwardly, the needle would be downwardly replaced. In addition, a sciatic femoral nerve block is performed.

PROCEDUREfemoral nerve blockade under ultrasound control without a peripheral nerve stimulator

Under ultrasound visualization guidance, the needle owas positioned at the femoral nerve (in plane) from its lateral side at a slightly superior position . A marker for LA introduction was the visualization of the needle end near the nerve. Subsequently, the introduction of LA solution was initiated. The position of the needle was corrected 1-2 times according to the type of anesthetic spread. If LA was spreading from the lateral side down to the nerve, then the needle was replaced to the upper point of the nerve and the rest of LA was introduced, and vice versa . The presence of a complete and incomplete spread of LA along the entire circumference of the nerve was assessed. Correspondingly, if the anesthetic was spreading upwardly, the needle would be downwardly replaced. In addition, a sciatic nerve block is performed.

Sponsors

Mogilev Regional Clinical Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* indication requiring anesthesia maintenance; * patient's written consent about the type of anesthesia and possible complications of regional anesthesia

Exclusion criteria

* patient's refusal of application for the proposed form of anesthesia; * patients younger than 18 years; * patients weighing less than 50 kg; * a physical status score of more than 3 determined by the American Society of Anesthesiologists (ASA); * a history of allergic reactions to the drugs used; * coagulopathies; * infections of the skin at the injection site; * neurological or neuromuscular diseases; * severe liver diseases or kidney failures; * an inability to cooperate with the patient.

Design outcomes

Primary

MeasureTime frameDescription
Сomplete sensory femoral nerve blockThe quality of sensory blocks was assessed after 45 minutes of administration of the sciatic nerve block. The evaluation of the block was carried out by an anesthesiologist who was not involved in the study, and was blinded to solution that had beenThe stimulus of the needle prick was applied to check the sensory block of thefemoral nerve. The assessment of skin sensitivity was carried out with the help of a similar scale: + +\\ indicating a complete sensory block; +\\ indicating a partial sensory block, a patient was unable to differentiate between the type of stimuli ; and -\\ indicating that the skin sensitivity was fully preserved.

Secondary

MeasureTime frameDescription
Сomplete motor femoral nerve blockThe quality of motor blocks was assessed after 45 minutes of administration of the sciatic nerve block. The evaluation of the block was carried out by an anesthesiologist who was not involved in the study, and was blinded to solution that had beenThe assessment of the motor block was carried out with the help of the following scale: + +\\ which indicated that movements were completely absent; +\\ which indicated that movements were partially preserved or were uncoordinated; and -\\ which indicated that movements were fully preserved.

Other

MeasureTime frameDescription
The need for additional pain relief during surgeryDuring the operation (start of operation - end of operation)The need for additional use of narcotic analgesics or local anesthesia during surgery (criterion-reporting of painful feelings during the operation). Based on the patient's complaint about pain of any intensity during the operation.

Countries

Belarus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026